16-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with leukotriene b4 in 1 studies
| Studies (16-hydroxy-5,8,11,14-eicosatetraenoic acid) | Trials (16-hydroxy-5,8,11,14-eicosatetraenoic acid) | Recent Studies (post-2010) (16-hydroxy-5,8,11,14-eicosatetraenoic acid) | Studies (leukotriene b4) | Trials (leukotriene b4) | Recent Studies (post-2010) (leukotriene b4) |
|---|---|---|---|---|---|
| 6 | 0 | 1 | 5,886 | 232 | 717 |
| Protein | Taxonomy | 16-hydroxy-5,8,11,14-eicosatetraenoic acid (IC50) | leukotriene b4 (IC50) |
|---|---|---|---|
| Leukotriene B4 receptor 1 | Homo sapiens (human) | 0.0019 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahern, TP; Balazy, M; Bednar, MM; Falck, JR; Fuller, SP; Gross, CE; Howard, DB; Reddy, KM; Russell, SR | 1 |
1 other study(ies) available for 16-hydroxy-5,8,11,14-eicosatetraenoic acid and leukotriene b4
| Article | Year |
|---|---|
16(R)-hydroxyeicosatetraenoic acid, a novel cytochrome P450 product of arachidonic acid, suppresses activation of human polymorphonuclear leukocyte and reduces intracranial pressure in a rabbit model of thromboembolic stroke.
Topics: Animals; Arachidonic Acid; Cell Adhesion; Cell Aggregation; Cytochrome P-450 Enzyme System; Drug Synergism; Fibrinolytic Agents; Humans; Hydroxyeicosatetraenoic Acids; Intracranial Embolism and Thrombosis; Intracranial Pressure; Leukotriene B4; Neutrophils; Rabbits; Single-Blind Method; Stroke; Tissue Plasminogen Activator | 2000 |